SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-15-000120
Filing Date
2015-02-13
Accepted
2015-02-13 15:01:29
Documents
1
Group Members
GROWTHWORKS ACCESS FUND LIMITED PARTNERSHIPGROWTHWORKS ACCESS GP I LTD.WORKING OPPORTUNITY FUND (EVCC) LTD.

Document Format Files

Seq Description Document Type Size
1 CELATOR PHARMACEUTICALS, INC. celator13g_17766.htm SC 13G/A 170774
  Complete submission text file 0001072613-15-000120.txt   172399
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Subject) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87438 | Film No.: 15613182
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5
Business Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5 604-895-7255
GrowthWorks Capital Ltd. (Filed by) CIK: 0001444153 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A